Author

Bart Klein

ProQR Therapeutics (Netherlands)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Anita M. van den Hoek· 1 shared Emy Theunissen· 1 shared Eva Coll-de la RubiaiD· 1 shared Francesco De ChiaraiD· 1 shared Galja Pletikapic· 1 shared Gerard J. PlatenburgiD· 1 shared Hans M. G. PrinceniD· 1 shared Janne J. TuruneniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Anita M. van den Hoek

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ADAR RNA editing for cardiovascular disease: Targeting B4GALT1 to modulate lipid metabolism through reduced galactosyltransferase activity

Francesco De Chiara, Eva Coll-de la Rubia, Petra de Bruijn, Galja Pletikapic, Nicole H.P. Cnubben, Lianne J. Stevens, Emy Theunissen, Janne J. Turunen, Anita M. van den Hoek, Hans M. G. Princen, Wouter Beumer, Seda Yilmaz-Elis, Bart Klein, Sjef J. de Kimpe, Gerard J. Platenburg

This study uses RNA editing to target B4GALT1 in mice, reducing lipid levels and coagulation factors without altering gene expression, suggesting potential for cardiovascular disease therapy.

Molecular Therapy — Nucleic Acids · Jul 9, 2026Peer-reviewedGenetics